Clinical Trial
Published on 08 Dec 2022
Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy
in Cancer Immunity and Immunotherapy
- 5,286 views
- 14 citations